Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Conduit Pharma Inc | Andrew James Regan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.32 per share. | 14 Jun 2024 | 10,244,392 | 1,691,727 | - | 0.3 | 3,246,448 | Common Stock |
| TeraWulf Inc | Paul B. Prager | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 14 Jun 2024 | 4,669,383 | 10,198,883 | - | - | Common stock, $0.001 par value per share | |
| TeraWulf Inc | Nazar M. Khan | Director, Chief Operating Officer + CTO | Other type of transaction at price $ 0.00 per share. | 14 Jun 2024 | 3,804,683 | 13,401,084 | - | - | Common stock, $0.001 par value per share | |
| Bridger Aerospace Grp Holdings Inc (Class A) | McAndrew Rudisill | Director, Chief Investment Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jun 2024 | 3,024,696 | 0 | - | 0 | Common Stock | |
| Core Scientific Inc - Ordinary Shares - New | Adam Taylor Sullivan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 2,867,521 | 3,006,434 | - | 0 | Common Stock | |
| Conduit Pharma Inc | Andrew James Regan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.26 per share. | 14 Jun 2024 | 1,514,100 | 177,627 | - | 0.3 | 391,092 | Common Stock |
| Expensify Inc (Class A) | David Barrett | Director, Chief Executive Officer | 14 Jun 2024 | 1,485,230 | 2,114,836 | - | - | LT10 Common Stock | ||
| Expensify Inc (Class A) | David Barrett | Director, Chief Executive Officer | 14 Jun 2024 | 1,485,230 | 2,062,237 | - | - | Class A Common Stock | ||
| Conduit Pharma Inc | Andrew James Regan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.25 per share. | 14 Jun 2024 | 1,389,820 | 12,941,319 | - | 0.2 | 343,425 | Common Stock |
| XBP Europe Holdings Inc | Par S. Chadha | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 1,128,972 | 1,128,972 | - | 0 | Common Stock, par value $0.0001 per share | |
| Conduit Pharma Inc | Andrew James Regan | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Jun 2024 | 1,100,000 | 30,048,454 | - | - | Common Stock | |
| Conduit Pharma Inc | Andrew James Regan | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Jun 2024 | 1,100,000 | 15,478,695 | - | - | Common Stock | |
| Conduit Pharma Inc | Andrew James Regan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.25 per share. | 14 Jun 2024 | 1,005,200 | 11,936,119 | - | 0.2 | 248,385 | Common Stock |
| Dell | Michael S. Dell | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 134.70 per share. | 14 Jun 2024 | 962,509 | 20,548,870 (8%) | 0% | 134.7 | 129,649,962 | Class C Common Stock |
| SoFi Tech Inc | Anthony J. Noto | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 960,346 | 5,649,376 | - | - | Restricted Stock Unit | |
| SoFi Tech Inc | Anthony J. Noto | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 960,346 | 9,082,190 | - | - | Common Stock | |
| Genie Energy Ltd (Class B) | Howard S. Jonas | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Jun 2024 | 950,398 | 950,398 (3%) | 3% | 0 | Class B Common Stock, par value $.01 per share | |
| Genie Energy Ltd (Class B) | Howard S. Jonas | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Jun 2024 | 950,398 | 0 (0%) | 3% | 0 | Class B Common Stock, par value $.01 per share | |
| Safety Shot Inc | Jordan Schur | Director, President | Grant, award, or other acquisition of securities at price $ 1.06 per share. | 14 Jun 2024 | 943,396 | 4,438,053 | - | 1.1 | 1,000,000 | Common Stock |
| Cellectar Biosciences Inc | James V. Caruso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 900,000 | 900,000 | - | - | Stock option (right to buy) | |
| XBP Europe Holdings Inc | Andrej Jonovic | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 877,570 | 877,570 | - | 0 | Common Stock, par value $0.0001 per share | |
| Core Scientific Inc - Ordinary Shares - New | Adam Taylor Sullivan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 716,881 | 3,723,315 | - | 0 | Common Stock | |
| Bridger Aerospace Grp Holdings Inc (Class A) | McAndrew Rudisill | Director, Chief Investment Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jun 2024 | 716,311 | 300,000 | - | 0 | Common Stock | |
| Dell | Michael S. Dell | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 133.91 per share. | 14 Jun 2024 | 708,584 | 21,511,379 (8%) | 0% | 133.9 | 94,886,483 | Class C Common Stock |
| Dell | Michael S. Dell | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 132.83 per share. | 14 Jun 2024 | 662,894 | 22,219,963 (8%) | 0% | 132.8 | 88,052,210 | Class C Common Stock |
| TransCode Therapeutics Inc | Thomas A. Fitzgerald | Director, Interim CEO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 650,000 | 650,000 | - | - | Stock Option (right to buy) | |
| Priority Technology Holdings | Thomas Charles Priore | Director, President, CEO and Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.56 per share. | 14 Jun 2024 | 598,187 | 34,319,476 (51%) | 0% | 3.6 | 2,129,546 | Common Stock |
| Priority Technology Holdings | John Vito Priore | Director, Ten Percent Owner | 14 Jun 2024 | 598,187 | 8,752,711 (13%) | 0% | 3.6 | 2,129,546 | Common Stock | |
| XBP Europe Holdings Inc | Vitalie Robu | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 586,449 | 586,449 | - | 0 | Common Stock, par value $0.0001 per share | |
| Conduit Pharma Inc | Andrew James Regan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.30 per share. | 14 Jun 2024 | 582,952 | 14,631,139 | - | 0.3 | 173,253 | Common Stock |
| SoFi Tech Inc | Anthony J. Noto | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.80 per share. | 14 Jun 2024 | 506,585 | 8,575,605 | - | 6.8 | 3,444,778 | Common Stock |
| Cellectar Biosciences Inc | Jarrod Longcor | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 500,000 | 500,000 | - | - | Stock option (right to buy) | |
| Adma Biologics Inc | Adam S. Grossman | Director, President,CEO, and Interim CFO | Other type of transaction at price $ 3.21 per share. | 14 Jun 2024 | 460,000 | 2,191,475 (2%) | 0% | 3.2 | 1,476,600 | Common Stock |
| TeraWulf Inc | Kerri M. Langlais | Director, Chief Strategy Officer | Other type of transaction at price $ 0.00 per share. | 14 Jun 2024 | 432,350 | 2,199,619 | - | - | Common stock, $0.001 par value per share | |
| Dell | Michael S. Dell | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 131.95 per share. | 14 Jun 2024 | 367,213 | 22,882,857 (8%) | 0% | 131.9 | 48,453,755 | Class C Common Stock |
| Nerdy Inc (Class A) | Charles Cohn | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.93 per share. | 14 Jun 2024 | 347,275 | 2,117,526 | - | 1.9 | 670,241 | Class A Common Stock |
| Cipher Mining Inc | Tyler Page | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 333,333 | 4,391,422 | - | - | Common Stock | |
| Cipher Mining Inc | Tyler Page | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 333,333 | 6,411,814 | - | - | Restricted Stock Units | |
| XBP Europe Holdings Inc | Dejan Avramovic | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 306,075 | 306,075 | - | 0 | Common Stock, par value $0.0001 per share | |
| Mach Natural Resources LP - Units | Kevin R. White | See Remarks, See Remarks | Sale of securities on an exchange or to another person at price $ 18.50 per share. | 14 Jun 2024 | 300,000 | 467,054 | - | 18.5 | 5,550,000 | Common Units |
| Conduit Pharma Inc | Andrew James Regan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.29 per share. | 14 Jun 2024 | 300,000 | 14,331,139 | - | 0.3 | 87,000 | Common Stock |
| Cellectar Biosciences Inc | Chad J. Kolean | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 290,000 | 290,000 | - | - | Stock option (right to buy) | |
| SoFi Tech Inc | Jeremy Rishel | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 271,571 | 662,187 | - | - | Common Stock | |
| SoFi Tech Inc | Jeremy Rishel | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 271,571 | 2,438,956 | - | - | Restricted Stock Unit | |
| Cellectar Biosciences Inc | Darrell Shane Lea | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 260,000 | 260,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | Andrei Shustov | Senior Vice President, Medical | 14 Jun 2024 | 260,000 | 260,000 | - | - | Stock option (right to buy) | ||
| Safety Shot Inc | Jordan Schur | Director, President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Jun 2024 | 250,000 | 0 | - | - | Common Stock | |
| Safety Shot Inc | Jordan Schur | Director, President | Grant, award, or other acquisition of securities at price $ 1.39 per share. | 14 Jun 2024 | 250,000 | 250,000 | - | 1.4 | 347,500 | Common Stock |
| Harmonic Inc | Nimrod Ben-Natan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 240,385 | 240,385 | - | - | Restricted Stock Units | |
| Core Scientific Inc - Ordinary Shares - New | Adam Taylor Sullivan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 238,961 | 3,962,276 | - | 0 | Common Stock | |
| SoFi Tech Inc | Christopher Lapointe | CFO and PAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 222,825 | 1,529,579 | - | - | Restricted Stock Unit | |
| SoFi Tech Inc | Christopher Lapointe | CFO and PAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 222,825 | 1,216,141 | - | - | Common Stock | |
| IDT Corp (Class B) | Howard S. Jonas | Director, Chairman, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Jun 2024 | 211,269 | 0 (0%) | 0% | 0 | Class B Common Stock, par value $.01 per share | |
| IDT Corp (Class B) | Howard S. Jonas | Director, Chairman, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Jun 2024 | 211,269 | 211,269 (0%) | 0% | 0 | Class B Common Stock, par value $.01 per share | |
| Solid Power Inc (Class A) | Joshua R. Buettner-Garrett | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 187,500 | 1,878,579 | - | - | Stock Option (Right to Buy) | |
| Solid Power Inc (Class A) | Joshua R. Buettner-Garrett | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 1.66 per share. | 14 Jun 2024 | 187,500 | 687,473 | - | 1.7 | 311,194 | Common Stock |
| Solid Power Inc (Class A) | Joshua R. Buettner-Garrett | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 14 Jun 2024 | 187,500 | 874,973 | - | 0.0 | 5,625 | Common Stock |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 176,309 | 176,309 | - | - | Class A Common Stock | |
| Cipher Mining Inc | Tyler Page | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.95 per share. | 14 Jun 2024 | 170,167 | 4,221,255 | - | 5.0 | 842,327 | Common Stock |
| Cipher Mining Inc | Patrick Kelly | Co-President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 166,666 | 2,711,500 | - | - | Restricted Stock Units | |
| Cipher Mining Inc | Patrick Kelly | Co-President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 166,666 | 723,773 | - | - | Common Stock | |
| Cipher Mining Inc | William Iwaschuk | Co-President and CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 166,666 | 2,711,500 | - | - | Restricted Stock Units | |
| Cipher Mining Inc | William Iwaschuk | Co-President and CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 166,666 | 696,998 | - | - | Common Stock | |
| SmartKem Inc | Ian Tudor Jenks | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 165,000 | 165,000 | - | - | Employee stock option (Right to Buy) | |
| Oportun Fin Corp | Raul Vazquez | Director, Chief Executive Officer | 14 Jun 2024 | 152,672 | 152,672 | - | - | Performance Stock Units | ||
| Oportun Fin Corp | Raul Vazquez | Director, Chief Executive Officer | 14 Jun 2024 | 152,672 | 1,259,715 (4%) | 0% | - | Common Stock | ||
| SoFi Tech Inc | Jeremy Rishel | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.39 per share. | 14 Jun 2024 | 152,450 | 509,737 | - | 6.4 | 974,765 | Common Stock |
| LifeStance Health Grp Inc | Danish J. Qureshi | See Remarks | Sale of securities on an exchange or to another person at price $ 5.21 per share. | 14 Jun 2024 | 150,000 | 439,002 | - | 5.2 | 781,515 | Common Stock |
| Conduit Pharma Inc | Andrew James Regan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.33 per share. | 14 Jun 2024 | 150,000 | 15,214,091 | - | 0.3 | 50,070 | Common Stock |
| SITE Centers Corp | Otto Alexander | Director | Sale of securities on an exchange or to another person at price $ 14.55 per share. | 14 Jun 2024 | 149,835 | 18,739,109 (9%) | 0% | 14.6 | 2,180,848 | Common Shares |
| SoFi Tech Inc | Derek Jensen White | CEO - Galileo | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 148,403 | 772,749 | - | - | Common Stock | |
| SoFi Tech Inc | Derek Jensen White | CEO - Galileo | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 148,403 | 1,102,840 | - | - | Restricted Stock Unit | |
| Dell | Michael S. Dell | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 135.44 per share. | 14 Jun 2024 | 136,629 | 20,412,241 (8%) | 0% | 135.4 | 18,505,032 | Class C Common Stock |
| Bumble Inc (Class A) | Elizabeth Monteleone | Chief Legal Officer | 14 Jun 2024 | 135,957 | 135,957 | - | - | Stock Option (right to buy) | ||
| Lyell Immunopharma Inc | Catherine J. Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 130,000 | 130,000 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | 14 Jun 2024 | 130,000 | 130,000 | - | - | Option (right to buy) | ||
| Lyell Immunopharma Inc | Otis W. Brawley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 130,000 | 130,000 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | William J. Rieflin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 130,000 | 130,000 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 130,000 | 130,000 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Richard D. Klausner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 130,000 | 130,000 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Elizabeth G. Nabel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 130,000 | 130,000 | - | - | Option (right to buy) | |
| Unitedhealth Grp | Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.16 per share. | 14 Jun 2024 | 118,270 | 810,847 (0%) | 0% | 111.2 | 13,146,893 | Common Stock |
| Unitedhealth Grp | Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 118,270 | 0 | - | - | Non-Qualified Stock Options (right to buy) | |
| SoFi Tech Inc | Christopher Lapointe | CFO and PAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.80 per share. | 14 Jun 2024 | 117,543 | 1,098,598 | - | 6.8 | 799,292 | Common Stock |
| Solid Power Inc (Class A) | John C. Van Scoter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.69 per share. | 14 Jun 2024 | 113,234 | 1,453,506 | - | 1.7 | 191,365 | Common Stock |
| SITE Centers Corp | Otto Alexander | Director | Sale of securities on an exchange or to another person at price $ 14.51 per share. | 14 Jun 2024 | 111,811 | 18,627,298 (9%) | 0% | 14.5 | 1,622,266 | Common Shares |
| FTC Solar Inc | Ahmad R. Chatila | Director | Purchase of securities on an exchange or from another person at price $ 0.45 per share. | 14 Jun 2024 | 108,062 | 1,190,246 | - | 0.5 | 48,628 | Common Stock |
| Adma Biologics Inc | Adam S. Grossman | Director, President,CEO, and Interim CFO | Sale of securities on an exchange or to another person at price $ 10.72 per share. | 14 Jun 2024 | 100,000 | 2,081,475 (2%) | 0% | 10.7 | 1,071,980 | Common Stock |
| SmartKem Inc | Barbra C. Keck | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 100,000 | 100,000 | - | - | Employee stock option (Right to Buy) | |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.75 per share. | 14 Jun 2024 | 97,052 | 79,257 | - | 23.8 | 2,304,985 | Class A Common Stock |
| Unitedhealth Grp | Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 96,706 | 0 | - | - | Non-Qualified Stock Options (right to buy) | |
| Unitedhealth Grp | Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 160.31 per share. | 14 Jun 2024 | 96,706 | 839,511 (0%) | 0% | 160.3 | 15,502,939 | Common Stock |
| Hims & Hers Health Inc (Class A) | Oluyemi Okupe | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 93,717 | 240,556 | - | - | Class A Common Stock | |
| Cipher Mining Inc | William Iwaschuk | Co-President and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.95 per share. | 14 Jun 2024 | 91,750 | 605,248 | - | 5.0 | 454,163 | Common Stock |
| Cellectar Biosciences Inc | Douglas J Swirsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 90,000 | 90,000 | - | - | Stock option (right to buy) | |
| Opendoor Tech Inc | Glenn Solomon | Director | 14 Jun 2024 | 87,960 | 209,110 | - | 0 | Common Stock | ||
| Opendoor Tech Inc | John Rice | Director | 14 Jun 2024 | 87,960 | 310,509 | - | 0 | Common Stock | ||
| Opendoor Tech Inc | Adam Bain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 87,960 | 315,205 | - | 0 | Common Stock | |
| Opendoor Tech Inc | Dana Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 87,960 | 157,864 | - | 0 | Common Stock | |
| Opendoor Tech Inc | Cipora Herman | Director | 14 Jun 2024 | 87,960 | 407,069 | - | 0 | Common Stock | ||
| Opendoor Tech Inc | Pueo Keffer | Director | 14 Jun 2024 | 87,960 | 669,692 | - | 0 | Common Stock | ||
| Opendoor Tech Inc | Eric Feder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 87,960 | 98,253 | - | 0 | Common Stock | |
| Church & Dwight | Richard A. Dierker | EVP, CFO & Head of Business Op | Sale of securities on an exchange or to another person at price $ 106.56 per share. | 14 Jun 2024 | 86,740 | 7,634 (0%) | 0% | 106.6 | 9,243,171 | Common Stock |
| Church & Dwight | Richard A. Dierker | EVP, CFO & Head of Business Op | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.54 per share. | 14 Jun 2024 | 86,740 | 94,374 (0%) | 0% | 84.5 | 7,333,000 | Common Stock |
| Church & Dwight | Richard A. Dierker | EVP, CFO & Head of Business Op | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 86,740 | 0 | - | - | Stock Option (right to buy) | |
| Bumble Inc (Class A) | Elizabeth Monteleone | Chief Legal Officer | 14 Jun 2024 | 86,465 | 122,367 | - | 0 | Class A Common Stock | ||
| Cipher Mining Inc | Patrick Kelly | Co-President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.95 per share. | 14 Jun 2024 | 85,083 | 638,690 | - | 5.0 | 421,161 | Common Stock |
| Expensify Inc (Class A) | David Barrett | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 81,620 | 215,289 | - | 0 | Class A Common Stock | |
| Coca-Cola | Nikolaos Koumettis | Europe OU President | Sale of securities on an exchange or to another person at price $ 62.34 per share. | 14 Jun 2024 | 80,891 | 218,880 (0%) | 0% | 62.3 | 5,042,996 | Common Stock, $.25 Par Value |
| Coca-Cola | Nikolaos Koumettis | Europe OU President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 80,891 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Coca-Cola | Nikolaos Koumettis | Europe OU President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.89 per share. | 14 Jun 2024 | 80,891 | 299,771 (0%) | 0% | 41.9 | 3,388,120 | Common Stock, $.25 Par Value |
| Oportun Fin Corp | Patrick Kirscht | Chief Credit Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 80,726 | 80,726 | - | - | Performance Stock Units | |
| Oportun Fin Corp | Patrick Kirscht | Chief Credit Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 80,726 | 349,550 (1%) | 0% | - | Common Stock | |
| Conduit Pharma Inc | Andrew James Regan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.44 per share. | 14 Jun 2024 | 77,681 | 15,364,091 | - | 0.4 | 33,853 | Common Stock |
| Expensify Inc (Class A) | Timothy L. Christen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 76,688 | 199,292 | - | 0 | Class A Common Stock | |
| Expensify Inc (Class A) | Ying Vivian Liu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 76,688 | 106,333 | - | 0 | Class A Common Stock | |
| Expensify Inc (Class A) | Ellen Pao | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 76,688 | 117,778 | - | 0 | Class A Common Stock | |
| Hims & Hers Health Inc (Class A) | Michael Chi | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 76,506 | 253,178 | - | - | Class A Common Stock | |
| Kopin Corp | Richard A. Sneider | Chief Financial Officer | 14 Jun 2024 | 75,000 | 526,744 (0%) | 0% | 0 | Common Stock | ||
| Kopin Corp | Paul Baker | Strategic Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 75,000 | 335,513 (0%) | 0% | 0 | Common Stock | |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 74,529 | 1,117,948 | - | - | Restricted Stock Unit | |
| W & T Offshore Inc | John D. Buchanan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 73,892 | 73,892 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Nancy T. Chang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 73,892 | 73,892 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Virginia Boulet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 73,892 | 73,892 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | B. Frank Stanley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 73,892 | 73,892 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Daniel O. Conwill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 73,892 | 73,892 | - | - | Restricted Stock Units | |
| Hims & Hers Health Inc (Class A) | Melissa Baird | Chief Operating Officer | 14 Jun 2024 | 73,146 | 614,578 | - | - | Class A Common Stock | ||
| TransCode Therapeutics Inc | Philippe P. Calais | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| TransCode Therapeutics Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| TransCode Therapeutics Inc | Erik Manting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| SoFi Tech Inc | Derek Jensen White | CEO - Galileo | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.39 per share. | 14 Jun 2024 | 69,445 | 703,304 | - | 6.4 | 444,031 | Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.09 per share. | 14 Jun 2024 | 69,148 | 2,853,595 | - | 1.1 | 75,371 | Class A Common Stock |
| Carvana Co. (Class A) | Thomas Taira | President, Special Projects | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 68,556 | 201,282 | - | - | Stock Options (Right to Buy) | |
| Carvana Co. (Class A) | Thomas Taira | President, Special Projects | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.07 per share. | 14 Jun 2024 | 68,556 | 254,953 (0%) | 0% | 10.1 | 690,359 | Class A Common Stock |
| Unitedhealth Grp | Stephen J. Hemsley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 496.83 per share. | 14 Jun 2024 | 68,042 | 742,805 (0%) | 0% | 496.8 | 33,805,307 | Common Stock |
| Cava Grp Inc | Brett Schulman | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 90.11 per share. | 14 Jun 2024 | 66,414 | 904,094 | - | 90.1 | 5,984,566 | Common Stock |
| XBP Europe Holdings Inc | Martin P. Akins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 65,421 | 65,421 | - | 0 | Common Stock, par value $0.0001 per share | |
| XBP Europe Holdings Inc | James G. Reynolds | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 65,421 | 65,421 | - | 0 | Common Stock, par value $0.0001 per share | |
| Unitedhealth Grp | Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 64,130 | 0 | - | - | Non-Qualified Stock Options (right to buy) | |
| Unitedhealth Grp | Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 262.98 per share. | 14 Jun 2024 | 64,130 | 858,255 (0%) | 0% | 263.0 | 16,864,907 | Common Stock |
| Unitedhealth Grp | Stephen J. Hemsley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 496.69 per share. | 14 Jun 2024 | 61,078 | 778,433 (0%) | 0% | 496.7 | 30,336,832 | Common Stock |
| Cogent Comm Holdings Inc | David Schaeffer | Director, CHAIRMAN, CEO, AND PRESIDENT, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 51.78 per share. | 14 Jun 2024 | 60,000 | 4,433,038 (9%) | 0% | 51.8 | 3,106,830 | common stock |
| Cellectar Biosciences Inc | Frederick W. Driscoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 60,000 | 60,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | John P. Neis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 60,000 | 60,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | Stefan D. Loren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 60,000 | 60,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | Asher Chanan-Khan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 60,000 | 60,000 | - | - | Stock option (right to buy) | |
| LoanDepot Inc (Class A) | Anthony Hsieh | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.84 per share. | 14 Jun 2024 | 58,063 | 2,279,646 (3%) | 0% | 1.8 | 107,126 | Class A Common Stock |
| SI-BONE Inc | Laura A. Francis | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 57,392 | 0 | - | - | Stock Option (Right to Buy) | |
| SI-BONE Inc | Laura A. Francis | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.32 per share. | 14 Jun 2024 | 57,392 | 502,890 (1%) | 0% | 4.3 | 247,933 | Common Stock |
| Church & Dwight | Patrick D. de Maynadier | EVP, Gen. Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 107.00 per share. | 14 Jun 2024 | 54,654 | 10,325 (0%) | 0% | 107.0 | 5,848,018 | Common Stock |
| Church & Dwight | Patrick D. de Maynadier | EVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 54,654 | 0 | - | - | Stock Option (right to buy) | |
| Church & Dwight | Patrick D. de Maynadier | EVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.28 per share. | 14 Jun 2024 | 54,654 | 64,979 (0%) | 0% | 50.3 | 2,748,022 | Common Stock |
| Unitedhealth Grp | Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 53,042 | 0 | - | - | Non-Qualified Stock Options (right to buy) | |
| Unitedhealth Grp | Stephen J. Hemsley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 226.64 per share. | 14 Jun 2024 | 53,042 | 831,475 (0%) | 0% | 226.6 | 12,021,439 | Common Stock |
| Hims & Hers Health Inc (Class A) | Oluyemi Okupe | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 52,395 | 366,767 | - | - | Restricted Stock Unit | |
| Hims & Hers Health Inc (Class A) | Oluyemi Okupe | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.75 per share. | 14 Jun 2024 | 51,561 | 188,995 | - | 23.8 | 1,224,574 | Class A Common Stock |
| Consumer Portfolio Service Inc | Charles E. Bradley | Director, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.98 per share. | 14 Jun 2024 | 50,000 | 3,790,092 (16%) | 0% | 9.0 | 449,000 | Common Stock, no par value |
| Rumble Inc (Class A) | Paul T. Cappuccio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 49,377 | 82,433 | - | 0 | Class A Common Stock, par value $0.0001 per share | |
| SmartKem Inc | Beverley Brown | Chief Scientist | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 49,000 | 49,000 | - | - | Employee stock option (Right to Buy) | |
| SmartKem Inc | Simon Ogier | Chief Technology Officer | 14 Jun 2024 | 49,000 | 49,000 | - | - | Employee stock option (Right to Buy) | ||
| Rackspace Tech Inc | Anthony Roberts | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.52 per share. | 14 Jun 2024 | 48,705 | 142,475 | - | 2.5 | 122,737 | Common Stock |
| Unitedhealth Grp | Stephen J. Hemsley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 496.66 per share. | 14 Jun 2024 | 47,716 | 810,539 (0%) | 0% | 496.7 | 23,698,629 | Common Stock |
| Rumble Inc (Class A) | Nancy Armstrong | Director | 14 Jun 2024 | 47,597 | 77,659 | - | 0 | Class A Common Stock, par value $0.0001 per share | ||
| Offerpad Soln Inc (Class A) | Benjamin Aronovitch | Chief Legal Officer | 14 Jun 2024 | 47,500 | 50,981 | - | 0 | Class A Common Stock | ||
| Expensify Inc (Class A) | Jason Mills | Director | Grant, award, or other acquisition of securities at price $ 1.35 per share. | 14 Jun 2024 | 47,168 | 261,825 | - | 1.4 | 63,677 | Class A Common Stock |
| Nautilus biotech Inc | Matthew S McIlwain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus biotech Inc | Farzad Nazem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus biotech Inc | Matthew L. Posard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus biotech Inc | Michael Altman | Director | 14 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | ||
| Nautilus biotech Inc | Karen Akinsanya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus biotech Inc | Melissa B. Epperly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus biotech Inc | Vijay Satyanand Pande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Hims & Hers Health Inc (Class A) | Soleil Boughton | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 43,208 | 197,553 | - | - | Class A Common Stock | |
| Hims & Hers Health Inc (Class A) | Michael Chi | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.75 per share. | 14 Jun 2024 | 42,303 | 210,875 | - | 23.7 | 1,004,696 | Class A Common Stock |
| Alset Inc | Fai Heng Chan | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 14 Jun 2024 | 42,149 | 5,611,539 | - | 1.1 | 48,471 | Common Stock |
| Ardelyx Inc | Richard J. Rodgers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 40,243 | 40,243 | - | - | Stock Option (Right to Buy) | |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 40,243 | 40,243 | - | - | Stock Option (Right to Buy) | |
| Ardelyx Inc | David M. Mott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 40,243 | 40,243 | - | - | Stock Option (Right to Buy) | |
| Ardelyx Inc | Robert B. Bazemore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 40,243 | 40,243 | - | - | Stock Option (Right to Buy) | |
| Ardelyx Inc | Onaiza Cadoret-Manier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 40,243 | 40,243 | - | - | Stock Option (Right to Buy) | |
| Ardelyx Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 40,243 | 40,243 | - | - | Stock Option (Right to Buy) | |
| Rezolute Inc | Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 4.04 per share. | 14 Jun 2024 | 40,000 | 40,000 | - | 4.0 | 161,568 | Common Shares |
| Cava Grp Inc | Brett Schulman | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.28 per share. | 14 Jun 2024 | 40,000 | 1,002,616 | - | 1.3 | 51,200 | Common Stock |
| Cava Grp Inc | Brett Schulman | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 40,000 | 78,805 | - | - | Stock Options (right to buy) | |
| Savers Value Village Inc | Duane C. Woods | Director | 14 Jun 2024 | 38,858 | 46,080 | - | 1.4 | 54,790 | Common Stock | |
| Savers Value Village Inc | Duane C. Woods | Director | 14 Jun 2024 | 38,858 | 43,820 | - | - | Option (Right to Purchase) | ||
| W & T Offshore Inc | Nancy T. Chang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 38,760 | 0 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Nancy T. Chang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 38,760 | 38,760 (0%) | 0% | - | Common Stock | |
| W & T Offshore Inc | Virginia Boulet | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 38,760 | 0 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Virginia Boulet | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 38,760 | 370,257 (0%) | 0% | - | Common Stock | |
| W & T Offshore Inc | B. Frank Stanley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 38,760 | 0 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | B. Frank Stanley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 38,760 | 319,733 (0%) | 0% | - | Common Stock | |
| W & T Offshore Inc | Daniel O. Conwill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 38,760 | 0 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Daniel O. Conwill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 38,760 | 73,736 (0%) | 0% | - | Common Stock | |
| Janus Henderson Grp PLC | Ali Dibadj | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.58 per share. | 14 Jun 2024 | 38,146 | 279,886 (0%) | 0% | 32.6 | 1,242,797 | Common Stock |
| McEwen Mining Inc | William M. Shaver | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 10.36 per share. | 14 Jun 2024 | 38,028 | 59,205 (0%) | 0% | 10.4 | 393,970 | Common Stock |
| Unitedhealth Grp | Stephen J. Hemsley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 496.86 per share. | 14 Jun 2024 | 37,350 | 794,125 (0%) | 0% | 496.9 | 18,557,721 | Common Stock |
| Trade Desk Inc (Class A) | Laura Schenkein | Chief Financial Officer | 14 Jun 2024 | 37,140 | 746,743 (1%) | 0% | 5.4 | 201,039 | Class A Common Stock | |
| Trade Desk Inc (Class A) | Laura Schenkein | Chief Financial Officer | 14 Jun 2024 | 37,140 | 122,687 | - | - | Employee Stock Option (Right to Buy) | ||
| Trade Desk Inc (Class A) | Laura Schenkein | Chief Financial Officer | 14 Jun 2024 | 37,140 | 709,603 (1%) | 0% | 95.4 | 3,544,270 | Class A Common Stock | |
| Lands` End Inc | Andrew J. McLean | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 36,885 | 286,504 | - | - | Restricted Stock Units | |
| Lands` End Inc | Andrew J. McLean | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 36,885 | 56,542 (0%) | 0% | 0 | Common Stock | |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 208.97 per share. | 14 Jun 2024 | 36,668 | 804,856 (0%) | 0% | 209.0 | 7,662,651 | Class A Common Stock |
| Conduit Pharma Inc | Andrew James Regan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.51 per share. | 14 Jun 2024 | 35,923 | 15,441,772 | - | 0.5 | 18,321 | Common Stock |
| Rumble Inc (Class A) | Robert Arsov | Director | 14 Jun 2024 | 35,587 | 15,077,337 | - | 0 | Class A Common Stock, par value $0.0001 per share | ||
| Rumble Inc (Class A) | Ryan Milnes | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 35,587 | 57,290 | - | 0 | Class A Common Stock, par value $0.0001 per share | |
| Rumble Inc (Class A) | Ethan Fallang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 35,587 | 62,779 | - | 0 | Class A Common Stock, par value $0.0001 per share | |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 35,446 | 389,912 | - | - | Restricted Stock Unit | |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 35,242 | 246,694 | - | - | Restricted Stock Unit | |
| Weave Comm Inc | Brett White | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.00 per share. | 14 Jun 2024 | 34,861 | 2,216,020 | - | 9 | 313,749 | Common Stock |
| CVB Fin Corp | George A. Borba | Director | Purchase of securities on an exchange or from another person at price $ 15.99 per share. | 14 Jun 2024 | 34,200 | 660,511 (0%) | 0% | 16.0 | 546,837 | Common Stock |
| Scilex Holding Co | Jaisim Shah | Director, See Remarks | 14 Jun 2024 | 33,333 | 33,333 | - | 1.4 | 47,000 | Common Stock | |
| Scilex Holding Co | Jaisim Shah | Director, See Remarks | 14 Jun 2024 | 33,333 | 166,667 | - | - | Nonstatutory Stock Option (right to buy) | ||
| Cava Grp Inc | Brett Schulman | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.93 per share. | 14 Jun 2024 | 32,108 | 970,508 | - | 89.9 | 2,887,472 | Common Stock |
| Expensify Inc (Class A) | Daniel Vidal | Director | Grant, award, or other acquisition of securities at price $ 1.35 per share. | 14 Jun 2024 | 31,693 | 178,348 | - | 1.4 | 42,786 | Class A Common Stock |
| SoFi Tech Inc | Anthony J. Noto | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.48 per share. | 14 Jun 2024 | 30,715 | 8,121,844 | - | 6.5 | 199,110 | Common Stock |
| Oportun Fin Corp | Kathleen I. Layton | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 30,535 | 30,535 | - | - | Performance Stock Units | |
| Oportun Fin Corp | Kathleen I. Layton | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 30,535 | 107,873 (0%) | 0% | - | Common Stock | |
| ePlus Inc | Mark P. Marron | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 30,269 | 105,372 (0%) | 0% | 0 | Common Stock | |
| Joby Aviation Inc | Michael P. Huerta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 30,181 | 30,181 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Laura H. Wright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 30,181 | 30,181 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Aicha Evans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 30,181 | 30,181 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Michael N. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 30,181 | 30,181 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Dipender Saluja | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 30,181 | 30,181 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Halimah DeLaine Prado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 30,181 | 30,181 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Paul Sciarra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 30,181 | 30,181 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Tetsuo Ogawa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 30,181 | 30,181 | - | - | Restricted Stock Units (RSUs) | |
| Federal Realty - REIT | Donald C. Wood | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jun 2024 | 30,146 | 124,780 (0%) | 0% | 0 | Common Shares of Beneficial Interest | |
| Federal Realty - REIT | Donald C. Wood | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jun 2024 | 30,146 | 219,405 (0%) | 0% | 0 | Common Shares of Beneficial Interest | |
| Celldex Therapeutics Inc | Elizabeth Crowley | SR. VP & CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.38 per share. | 14 Jun 2024 | 30,000 | 39,074 (0%) | 0% | 10.4 | 311,400 | Common Stock |
| Celldex Therapeutics Inc | Elizabeth Crowley | SR. VP & CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 30,000 | 46,500 | - | - | Incentive Stock Option (Right to Buy) | |
| Celldex Therapeutics Inc | Elizabeth Crowley | SR. VP & CPDO | Sale of securities on an exchange or to another person at price $ 34.87 per share. | 14 Jun 2024 | 30,000 | 9,074 (0%) | 0% | 34.9 | 1,045,962 | Common Stock |
| International Paper | William Thomas Hamic | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 30,000 | 99,211 (0%) | 0% | 0 | Common Stock | |
| Ollies Bargain Outlet Holdings Inc | Stanley Fleishman | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jun 2024 | 29,520 | 29,797 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Shift4 Payments Inc (Class A) | Jared Isaacman | Director, Chairman & CEO, Ten Percent Owner | 14 Jun 2024 | 29,061 | 1,494,032 | - | 0 | Class C Common Stock | ||
| Hims & Hers Health Inc (Class A) | Melissa Baird | Chief Operating Officer | 14 Jun 2024 | 28,778 | 585,800 | - | 23.8 | 683,478 | Class A Common Stock | |
| Comstock Resources Inc | Miles Jay Allison | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.15 per share. | 14 Jun 2024 | 28,516 | 2,334,660 (1%) | 0% | 11.1 | 317,953 | Common Stock |
| Hagerty Inc (Class A) | Robert I. Kauffman | Director | Sale of securities on an exchange or to another person at price $ 10.29 per share. | 14 Jun 2024 | 28,297 | 3,236,542 | - | 10.3 | 291,176 | Class A Common Stock |
| Arcutis Biotherapeutics Inc | Keith R. Leonard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 27,052 | 27,052 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | 14 Jun 2024 | 27,052 | 27,052 | - | - | Stock Option (right to buy) | ||
| Arcutis Biotherapeutics Inc | Patrick J. Heron | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 27,052 | 27,052 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 27,052 | 27,052 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Terrie Curran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 27,052 | 27,052 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 27,052 | 27,052 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Neha Krishnamohan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 27,052 | 27,052 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Sue-Jean Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 27,052 | 27,052 | - | - | Stock Option (right to buy) | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 14 Jun 2024 | 26,840 | 5,487,064 (1%) | 0% | 0 | Common Stock | |
| Wayfair Inc (Class A) | Fiona Tan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 26,183 | 26,183 | - | - | Restricted Stock Unit ("RSU") | |
| Hims & Hers Health Inc (Class A) | Melissa Baird | Chief Operating Officer | 14 Jun 2024 | 26,133 | 392,008 | - | - | Restricted Stock Unit | ||
| Carvana Co. (Class A) | Thomas Taira | President, Special Projects | Sale of securities on an exchange or to another person at price $ 102.88 per share. | 14 Jun 2024 | 26,102 | 202,855 (0%) | 0% | 102.9 | 2,685,374 | Class A Common Stock |
| Carvana Co. (Class A) | Thomas Taira | President, Special Projects | Sale of securities on an exchange or to another person at price $ 101.92 per share. | 14 Jun 2024 | 25,996 | 228,957 (0%) | 0% | 101.9 | 2,649,512 | Class A Common Stock |
| Hims & Hers Health Inc (Class A) | Michael Chi | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 23.59 per share. | 14 Jun 2024 | 25,549 | 185,326 | - | 23.6 | 602,701 | Class A Common Stock |
| Wayfair Inc (Class A) | Thomas Netzer | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 25,383 | 25,383 | - | - | Restricted Stock Unit ("RSUs") | |
| Xilio Therapeutics Inc | Paul J. Clancy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Sara M. Bonstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Christina Rossi | Director | 14 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | ||
| Xilio Therapeutics Inc | Daniel Curran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| SLR Investment Corp | Andrea C. Roberts | Director | Purchase of securities on an exchange or from another person at price $ 15.98 per share. | 14 Jun 2024 | 25,000 | 25,000 (0%) | 0% | 16.0 | 399,500 | Common Stock |
| Oportun Fin Corp | Jonathan Coblentz | CFO & Chief Admin Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 24,667 | 24,667 | - | - | Performance Stock Units | |
| Oportun Fin Corp | Jonathan Coblentz | CFO & Chief Admin Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 24,667 | 236,188 (0%) | 0% | - | Common Stock | |
| Weave Comm Inc | Marcus Bertilson | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.00 per share. | 14 Jun 2024 | 24,165 | 350,835 | - | 9 | 217,485 | Common Stock |
| Hims & Hers Health Inc (Class A) | Irene Becklund | PAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 24,088 | 24,088 | - | - | Class A Common Stock | |
| Mitek Systems Inc | Christopher H Briggs | SVP Identity | 14 Jun 2024 | 24,000 | 68,673 (0%) | 0% | 11.1 | 266,400 | Common Stock | |
| Hims & Hers Health Inc (Class A) | Soleil Boughton | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.75 per share. | 14 Jun 2024 | 23,739 | 173,814 | - | 23.7 | 563,801 | Class A Common Stock |
| Prelude Therapeutics Inc | Martin Babler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,500 | 23,500 | - | - | Director Stock Option (Right to Buy) | |
| Prelude Therapeutics Inc | Paul A. Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,500 | 23,500 | - | - | Director Stock Option (Right to Buy) | |
| Prelude Therapeutics Inc | David P. Bonita | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,500 | 23,500 | - | - | Director Stock Option (Right to Buy) | |
| Prelude Therapeutics Inc | Mardi C. Dier | Director | 14 Jun 2024 | 23,500 | 23,500 | - | - | Director Stock Option (Right to Buy) | ||
| Prelude Therapeutics Inc | Victor Sandor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,500 | 23,500 | - | - | Director Stock Option (Right to Buy) | |
| McEwen Mining Inc | Perry Y. Ing | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 10.36 per share. | 14 Jun 2024 | 23,332 | 38,883 (0%) | 0% | 10.4 | 241,720 | Common Stock |
| McEwen Mining Inc | Perry Y. Ing | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.76 per share. | 14 Jun 2024 | 23,332 | 15,551 (0%) | 0% | 9.8 | 227,720 | Common Stock |
| Olema Pharma Inc | Andrew S. Rappaport | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option (right to buy) | |
| Olema Pharma Inc | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option (right to buy) | |
| Olema Pharma Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option (right to buy) | |
| Olema Pharma Inc | Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option (right to buy) | |
| Olema Pharma Inc | Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option (right to buy) | |
| Olema Pharma Inc | Yi Larson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Gorjan Hrustanovic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option (right to buy) | |
| Olema Pharma Inc | Cyrus L. Harmon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option (Right to Buy) | |
| Hims & Hers Health Inc (Class A) | Oluyemi Okupe | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 22,988 | 344,821 | - | - | Restricted Stock Unit | |
| Hewlett Packard | Gerri A. Gold | EVP, Pres & CEO Financial Serv | 14 Jun 2024 | 22,784 | 57,081 (0%) | 0% | 21.7 | 493,816 | Common Stock | |
| Joby Aviation Inc | Michael P. Huerta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 22,556 | 30,346 | - | 0 | Common Stock | |
| Joby Aviation Inc | Michael P. Huerta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 22,556 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Laura H. Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 22,556 | 85,462 | - | 0 | Common Stock | |
| Joby Aviation Inc | Laura H. Wright | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 22,556 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Reid G. Hoffman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 22,556 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Reid G. Hoffman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 22,556 | 102,603 | - | 0 | Common Stock | |
| Joby Aviation Inc | Aicha Evans | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 22,556 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Aicha Evans | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 22,556 | 87,447 | - | 0 | Common Stock | |
| Joby Aviation Inc | Dipender Saluja | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 22,556 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Dipender Saluja | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 22,556 | 102,603 | - | 0 | Common Stock | |
| Joby Aviation Inc | Halimah DeLaine Prado | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 22,556 | 74,736 | - | 0 | Common Stock | |
| Joby Aviation Inc | Halimah DeLaine Prado | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 22,556 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Paul Sciarra | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 22,556 | 100,070 | - | 0 | Common Stock | |
| Joby Aviation Inc | Paul Sciarra | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 22,556 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Funko Inc (Class A) | Michael C. Lunsford | Director | Sale of securities on an exchange or to another person at price $ 10.38 per share. | 14 Jun 2024 | 22,404 | 99,074 (0%) | 0% | 10.4 | 232,634 | CLASS A COMMON STOCK |
| Ridgepost Capital Inc | Robert B. Stewart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 21,875 | 113,180 | - | 0 | Class A Common Stock | |
| Ridgepost Capital Inc | Travis Barnes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 21,875 | 47,090 | - | 0 | Class A Common Stock | |
| Ridgepost Capital Inc | Scott Gwilliam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 21,875 | 47,090 | - | 0 | Class A Common Stock | |
| Ridgepost Capital Inc | Tracey Benford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 21,875 | 21,875 | - | 0 | Class A Common Stock | |
| Wayfair Inc (Class A) | Kate Gulliver | CFO and Chief Admin Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 20,749 | 20,749 | - | - | Restricted Stock Unit ("RSU") | |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 102.92 per share. | 14 Jun 2024 | 20,641 | 1,256,818 (2%) | 0% | 102.9 | 2,124,345 | Class A Common Stock |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 101.94 per share. | 14 Jun 2024 | 20,041 | 1,277,459 (2%) | 0% | 101.9 | 2,043,042 | Class A Common Stock |
| Universal Insurance Holdings Inc | Sean P. Downes | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 18.31 per share. | 14 Jun 2024 | 20,000 | 1,142,262 (3%) | 0% | 18.3 | 366,280 | Common Stock |
| Triller Grp Inc | Suet Fai Almond Wong | Group Chief Operating Officer | Sale or transfer of securities back to the company at price $ 62901.08 per share. | 14 Jun 2024 | 20,000 | 960,980 | - | 62901.1 | 1,258,021,600 | Ordinary Shares |
| Orion Energy Systems Inc | Ellen B. Richstone | Director | Purchase of securities on an exchange or from another person at price $ 1.14 per share. | 14 Jun 2024 | 20,000 | 256,784 (0%) | 0% | 1.1 | 22,900 | Common Stock |
| SmartKem Inc | Sriram Peruvemba | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 20,000 | 20,000 | - | - | Employee stock option (Right to Buy) | |
| SmartKem Inc | Klaas de Boer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 20,000 | 20,000 | - | - | Employee stock option (Right to Buy) | |
| SmartKem Inc | Steven P. DenBaars | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 20,000 | 20,000 | - | - | Employee stock option (Right to Buy) | |
| SmartKem Inc | Melisa A. Denis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 20,000 | 20,000 | - | - | Employee stock option (Right to Buy) | |
| Sonos Inc | Chris Mason | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.28 per share. | 14 Jun 2024 | 20,000 | 142,009 (0%) | 0% | 11.3 | 225,500 | Common Stock |
| Sonos Inc | Chris Mason | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 20,000 | 10,000 | - | - | Employee Stock Option (Right to Buy) | |
| Sonos Inc | Chris Mason | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 15.44 per share. | 14 Jun 2024 | 20,000 | 122,009 (0%) | 0% | 15.4 | 308,800 | Common Stock |
| ADT Inc | Danielle Tiedt | Director | Grant, award, or other acquisition of securities at price $ 7.29 per share. | 14 Jun 2024 | 19,564 | 19,564 | - | 7.3 | 142,622 | Restricted Stock Units |
| ADT Inc | Daniel J. Houston | Director | Grant, award, or other acquisition of securities at price $ 7.29 per share. | 14 Jun 2024 | 19,564 | 19,564 | - | 7.3 | 142,622 | Restricted Stock Units |
| Nektar Therapeutics | Robert B. Chess | Director | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 14 Jun 2024 | 19,500 | 255,273 (0%) | 0% | 1.2 | 23,400 | Common Stock |
| Comstock Resources Inc | Roland O. Burns | Director, President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.15 per share. | 14 Jun 2024 | 19,384 | 1,310,215 (0%) | 0% | 11.2 | 216,132 | Common Stock |
| Hims & Hers Health Inc (Class A) | Michael Chi | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 19,358 | 290,376 | - | - | Restricted Stock Unit | |
| Hovnanian Enterprises Inc (Class A) | Ara K. Hovnanian | Director, Chairman of Bd., Pres. & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 19,086 | 19,086 | - | - | Performance Share Units (2024) | |
| Expensify Inc (Class A) | David Barrett | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.30 per share. | 14 Jun 2024 | 18,730 | 2,007,827 | - | 1.3 | 24,349 | Class A Common Stock |
| Hims & Hers Health Inc (Class A) | Melissa Baird | Chief Operating Officer | 14 Jun 2024 | 18,713 | 130,988 | - | - | Restricted Stock Unit | ||
| Trinity Cap Inc | Steven L. Brown | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.82 per share. | 14 Jun 2024 | 18,632 | 721,464 | - | 14.8 | 276,126 | Common Stock |
| National Vision Holdings Inc | Jose Armario | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 18,616 | 39,031 (0%) | 0% | 0 | Common Stock | |
| ePlus Inc | Elaine D. Marion | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 18,574 | 64,462 (0%) | 0% | 0 | Common Stock | |
| ePlus Inc | Darren S. Raiguel | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 18,574 | 64,697 (0%) | 0% | 0 | Common Stock | |
| Cherry Hill Mortgage Investment Corp | Joseph J. Murin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 18,568 | 78,134 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Cherry Hill Mortgage Investment Corp | Robert C. Mercer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 18,568 | 68,175 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Cherry Hill Mortgage Investment Corp | Sharon L. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 18,568 | 32,513 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Hims & Hers Health Inc (Class A) | Oluyemi Okupe | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 18,334 | 201,679 | - | - | Restricted Stock Unit | |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 18,290 | 54,867 | - | - | Restricted Stock Unit | |
| Wayfair Inc (Class A) | Jon Blotner | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 18,256 | 18,256 | - | - | Restricted Stock Units ("RSUs") | |
| Service Properties Trust | John L. Harrington | Director | 14 Jun 2024 | 18,255 | 18,255 (0%) | 0% | - | Common Shares of Beneficial Interest | ||
| Service Properties Trust | John L. Harrington | Director | 14 Jun 2024 | 18,255 | 0 (0%) | 0% | 0 | Common Shares of Beneficial Interest | ||
| Service Properties Trust | John L. Harrington | Director | 14 Jun 2024 | 18,255 | 39,255 (0%) | 0% | 0 | Common Shares of Beneficial Interest | ||
| Service Properties Trust | Laurie B. Burns | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 18,255 | 47,255 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Service Properties Trust | William A. Lamkin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jun 2024 | 18,255 | 0 (0%) | 0% | 0 | Common Shares of Beneficial Interest | |
| Service Properties Trust | William A. Lamkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 18,255 | 18,255 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Service Properties Trust | William A. Lamkin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jun 2024 | 18,255 | 73,255 (0%) | 0% | 0 | Common Shares of Beneficial Interest | |
| Service Properties Trust | Adam D. Portnoy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 18,255 | 193,754 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Service Properties Trust | John G. Murray | Director | 14 Jun 2024 | 18,255 | 248,548 (0%) | 0% | - | Common Shares of Beneficial Interest | ||
| Service Properties Trust | Donna Fraiche | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 18,255 | 58,255 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Service Properties Trust | Rajan C. Penkar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 18,255 | 25,255 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Service Properties Trust | Robert E. Cramer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 18,255 | 47,255 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Trinity Cap Inc | Kyle Brown | Director, CEO, President and CIO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.82 per share. | 14 Jun 2024 | 18,026 | 971,798 | - | 14.8 | 267,145 | Common Stock |
| Hovnanian Enterprises Inc (Class A) | Ara K. Hovnanian | Director, Chairman of Bd., Pres. & CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 18,000 | 277,910 | - | - | Class B Common Stock | |
| Hovnanian Enterprises Inc (Class A) | Ara K. Hovnanian | Director, Chairman of Bd., Pres. & CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 18,000 | 295,910 | - | - | Class B Common Stock | |
| DocGo Inc | Lee Bienstock | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.04 per share. | 14 Jun 2024 | 17,984 | 1,202,861 | - | 4.0 | 72,655 | Common Stock |
| Expensify Inc (Class A) | David Barrett | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.37 per share. | 14 Jun 2024 | 17,940 | 2,026,557 | - | 1.4 | 24,578 | Class A Common Stock |
| Rumble Inc (Class A) | Paul T. Cappuccio | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.76 per share. | 14 Jun 2024 | 17,762 | 33,056 | - | 5.8 | 102,309 | Class A Common Stock, par value $0.0001 per share |
| Expensify Inc (Class A) | David Barrett | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.38 per share. | 14 Jun 2024 | 17,740 | 2,044,497 | - | 1.4 | 24,481 | Class A Common Stock |
| Cars.com | Thomas Alex Vetter | Director, CEO | Sale of securities on an exchange or to another person at price $ 20.09 per share. | 14 Jun 2024 | 17,666 | 616,608 (0%) | 0% | 20.1 | 354,910 | Common Stock |
| National Vision Holdings Inc | Thomas V. Taylor | Director | 14 Jun 2024 | 17,645 | 52,328 (0%) | 0% | 0 | Common Stock | ||
| Harmonic Inc | Walter F. Jankovic | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 17,483 | 17,483 | - | - | Restricted Stock Units | |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 103.75 per share. | 14 Jun 2024 | 17,423 | 1,239,395 (2%) | 0% | 103.8 | 1,807,692 | Class A Common Stock |
| Autodesk | Steven M. Blum | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 226.40 per share. | 14 Jun 2024 | 17,413 | 54,136 (0%) | 0% | 226.4 | 3,942,303 | Common Stock |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 209.58 per share. | 14 Jun 2024 | 17,326 | 787,530 (0%) | 0% | 209.6 | 3,631,195 | Class A Common Stock |
| Ardelyx Inc | David M. Mott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 17,322 | 1,209,597 (1%) | 0% | 0 | Common Stock | |
| Celldex Therapeutics Inc | Sam Martin | SVP AND CFO | Sale of securities on an exchange or to another person at price $ 35.42 per share. | 14 Jun 2024 | 17,172 | 28,125 (0%) | 0% | 35.4 | 608,315 | Common Stock |
| Ibotta Inc (Class A) | David T. Shapiro | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 17,124 | 34,506 | - | 0 | Class A Common Stock | |
| McEwen Mining Inc | Carmen L. Diges | General Counsel/Corp Sec | Grant, award, or other acquisition of securities at price $ 10.36 per share. | 14 Jun 2024 | 17,066 | 28,048 (0%) | 0% | 10.4 | 176,804 | Common Stock |
| Celldex Therapeutics Inc | Sam Martin | SVP AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.38 per share. | 14 Jun 2024 | 16,968 | 45,297 (0%) | 0% | 10.4 | 176,128 | Common Stock |
| Celldex Therapeutics Inc | Sam Martin | SVP AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 16,968 | 63,632 | - | - | Incentive Stock Option (Right to Buy) | |
| Joby Aviation Inc | Tetsuo Ogawa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 16,864 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Tetsuo Ogawa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 16,864 | 23,019 | - | 0 | Common Stock | |
| Corbus Pharma Holdings Inc | Yuval Cohen | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.10 per share. | 14 Jun 2024 | 16,830 | 101,230 (0%) | 0% | 14.1 | 237,303 | Common Stock, par value $0.0001 per share |
| Corbus Pharma Holdings Inc | Yuval Cohen | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 50.17 per share. | 14 Jun 2024 | 16,830 | 84,400 (0%) | 0% | 50.2 | 844,297 | Common Stock, par value $0.0001 per share |
| Corbus Pharma Holdings Inc | Yuval Cohen | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 16,830 | 32,827 | - | - | Options to purchase common stock | |
| Oportun Fin Corp | Casey Mueller | Global Controller and PAO | 14 Jun 2024 | 16,540 | 201,275 (0%) | 0% | - | Common Stock | ||
| Hims & Hers Health Inc (Class A) | Michael Chi | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 16,495 | 148,461 | - | - | Restricted Stock Unit | |
| Hims & Hers Health Inc (Class A) | Melissa Baird | Chief Operating Officer | 14 Jun 2024 | 16,297 | 179,270 | - | - | Restricted Stock Unit | ||
| Hims & Hers Health Inc (Class A) | Michael Chi | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 16,297 | 179,270 | - | - | Restricted Stock Unit | |
| Rumble Inc (Class A) | Nancy Armstrong | Director | 14 Jun 2024 | 16,254 | 30,062 | - | 5.8 | 93,623 | Class A Common Stock, par value $0.0001 per share | |
| AMD | Mark D. Papermaster | Chief Technology Officer & EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.83 per share. | 14 Jun 2024 | 16,200 | 1,562,427 (0%) | 0% | 12.8 | 207,846 | Common Stock |
| AMD | Mark D. Papermaster | Chief Technology Officer & EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 16,200 | 16,756 | - | - | Stock Option | |
| Caredx Inc | Fred E. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 16,048 | 16,048 | - | - | Stock Option (right to buy) | |
| Caredx Inc | George W. Bickerstaff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 16,048 | 16,048 | - | - | Stock Option (right to buy) | |
| Caredx Inc | Michael D. Goldberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 16,048 | 16,048 | - | - | Stock Option (right to buy) | |
| Caredx Inc | William A. Hagstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 16,048 | 16,048 | - | - | Stock Option (right to buy) | |
| Caredx Inc | Peter Maag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 16,048 | 16,048 | - | - | Stock Option (right to buy) | |
| Caredx Inc | Hannah A. Valantine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 16,048 | 16,048 | - | - | Stock Option (right to buy) | |
| Caredx Inc | Arthur A. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 16,048 | 16,048 | - | - | Stock Option (right to buy) | |
| Caredx Inc | Fred E. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 16,048 | 16,048 | - | - | Stock Option (right to buy) | |
| Caredx Inc | George W. Bickerstaff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 16,048 | 16,048 | - | - | Stock Option (right to buy) | |
| Caredx Inc | Michael D. Goldberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 16,048 | 16,048 | - | - | Stock Option (right to buy) | |
| Caredx Inc | Peter Maag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 16,048 | 16,048 | - | - | Stock Option (right to buy) | |
| Caredx Inc | Hannah A. Valantine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 16,048 | 16,048 | - | - | Stock Option (right to buy) | |
| Caredx Inc | Arthur A. Torres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 16,048 | 16,048 | - | - | Stock Option (right to buy) | |
| Caredx Inc | William A. Hagstrom | Director | 14 Jun 2024 | 16,048 | 16,048 | - | - | Stock Option (right to buy) | ||
| Caredx Inc | Christine M. Cournoyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 16,048 | 16,048 | - | - | Stock Option (right to buy) | |
| Oxford Ind Inc | Thomas E. Campbell | EVP | Sale of securities on an exchange or to another person at price $ 99.81 per share. | 14 Jun 2024 | 16,040 | 26,365 (0%) | 0% | 99.8 | 1,601,001 | Common Stock |
| Alignment Healthcare Inc | Christopher J. Joyce | Chief Legal and Admin. Officer | Sale of securities on an exchange or to another person at price $ 8.01 per share. | 14 Jun 2024 | 16,000 | 422,912 | - | 8.0 | 128,198 | Common Stock |
| SmartKem Inc | Ian Tudor Jenks | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 16,000 | 16,000 | - | - | Employee stock option (Right to Buy) | |
| National Vision Holdings Inc | Susan Somersille Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 15,637 | 36,308 (0%) | 0% | 0 | Common Stock | |
| Lands` End Inc | Andrew J. McLean | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.42 per share. | 14 Jun 2024 | 15,617 | 40,925 (0%) | 0% | 14.4 | 225,197 | Common Stock |
| DocGo Inc | Lee Bienstock | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.16 per share. | 14 Jun 2024 | 15,565 | 1,187,296 | - | 3.2 | 49,185 | Common Stock |
| GlucoTrack Inc | Paul V. Goode | Director, Chief Executive Officer | 14 Jun 2024 | 15,435 | 18,989 | - | 0 | Common Stock, par value $0.001 per share | ||
| Jade Biosciences Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 15,000 | 28,763 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 14 Jun 2024 | 15,000 | 20,022 | - | 2.1 | 32,100 | Common Stock |
| Jade Biosciences Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 14 Jun 2024 | 15,000 | 5,022 | - | 25.0 | 375,450 | Common Stock |
| Arcturus Therapeutics Holdings Inc | James F. Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 15,000 | 15,000 | - | - | Stock option (right to buy) |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.